Literature Review: Hubungan Kadar D-Dimer dengan Tingkat Keparahan Pasien Covid-19
Literature Review: The Relationship of D-Dimer Levels with the Sverity of Covid-19
DOI:
https://doi.org/10.33084/jsm.v9i2.5726Keywords:
D-dimer, Tingkat Keparahan, COVID-19Abstract
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causes Corona Virus Disease-19 (COVID-19). D-dimer is one of the hemostasis tests performed on patients infected with the disease, it is a product of fibrin degradation and a biomarker of platelet disorders. With the development of COVID-19 as a pandemic, D-dimer has become an indicator for prognosis in COVID-19 patients. Based on symptoms, the severity of COVID-19 patients consists of mild, moderate, and severe symptoms. The author conducted a literature review regarding the correlation between D-dimer levels and the severity of COVID-19 patients. Data and theory were taken from ten references from several databases: Google Scholar, PubMed, Semantic Scholar, Science Direct, Garuda, and Neliti. The references taken were from the 2020-2022 range. In all of these references, statistical test results were obtained with a significant value below 0.05, so it can be concluded that there is a correlation between D-dimer levels and the severity of COVID-19. In COVID-19 infections with severe symptoms, immunothrombosis can occur due to hyperinflammatory conditions and cytokine storms. Immunothrombosis occurs as a result of the body's defense against viral infections. Damage to lung tissue in COVID-19 patients triggers a procoagulant response associated with inflammatory cytokines in blood vessel tissue.
Downloads
References
Angela, K. and Sumohadi, I., (2022). Hubungan D-dimer dengan Tingkat Keparahan Infeksi COVID-19. Intisari Sains Medis, 13(2), pp.393–398. https://doi.org/10.15562/ism.v13i2.1412.
Asih, N.W.S., (2022). Hubungan NLR, Kadar CRP dan D-dimer terhadap Derajat Keparahan Penyakit Pasien COVID-19 di RSUD Wangaya Denpasar. Jurnal Medika Udayana, 11(12), pp.14–21.
Atmaja, K.S., Wicaksana, A.A.G.O.S., Putra, I.W.A.S. and Putra, W.W.S., (2021). Hubungan Konsentrasi Serum C-Reactive Protein dan D-dimer dengan Derajat Keparahan dan Mortalitas pasien COVID-19. Intisari Sains Medis, 12(2), pp.680–685. https://doi.org/10.15562/ism.v12i2.971.
Bohn, M.K., Hall, A., Sepiashvili, L., Jung, B., Steele, S. and Adeli, K., (2020). Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology, https://doi.org/10.1152/physiol.00019.2020.
Driggin, E., Madhavan, M. V, Bikdeli, B., Chuich, T. and Harm, P.D., (2020). Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During The Coronavirus Disease 2019 (COVID-19) Pandemic. Journal of the American College of cardiology, 75(18), pp.2352–2371.
Duz M, Balci A and Menekse E, (2020). D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis. Tuber Toraks, 68(4), pp.353–360.
Fu, J., Kong, J., Wang, W., Wu, M., Yao, L. and Wang, Z., (2020). The Clinical Implication of Dynamic Neutrophil to Lymphocyte Ratio and D-dimer in COVID-19: A Retrospective Study in Suzhou China. Thrombosis Research, (January), pp.3–8.
Guan W, Ni Z, Hu Y and Liang W, (2020). Clinical characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382, pp.1708–1720.
Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, Tan K, Wang D and Yan Y, (2020). The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak-An Update on The Status. Military Medical Research, https://doi.org/10.1186/s40779-020-00240-0.
Hashem, M.K., Khedr, E.M., Daef, E., Mohamed-Hussein, A., Mostafa, E.F., Hassany, S.M., Galal, H., Hassan, S.A., Galal, I., Amin, M.T. and Hassan, H.M., (2021). Prognostic Biomarkers in COVID-19 Infection: Value of Anemia, Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and D-dimer. The Egyptian Journal of Bronchology, 15(29), pp.1–9. https://doi.org/10.1186/s43168-021-00075-w.
Herdiman, H., Basyar, M. and Khairsyaf, O., (2022). Association Between D-Dimer Level with Clinical Severity and Radiological Imaging of Confirmed COVID-19 Patients at RSUP Dr. M. Djamil Padang. Jurnal Respirologi Indonesia, 42(4), pp.328–334. https://doi.org/10.36497/jri.v42i4.241.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J and Cao B, (2020). Clinical features of patients infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395, pp.497–506.
Jabar, F.A.A., Ahmid, D.S. and Lateef, A.A., (2022). Study Some of Inflammatory Indicator with Corona Patient and Relation with Chronic Disease. Technium BioChemMed, 3(1), pp.7–16. https://doi.org/10.47577/biochemmed.v3i1.5716.
KEMENKES, (2020). Pedoman Kesiapsiagaan Menghadapi Covid-19. Jakarta Selatan: Direktorat Jenderal Pencegahan dan Pengendalian Penyakit (P2P).
Listyoko, A.S., Djajalaksana, S. and Sugiri, Y.J., (2021). Analisis Fibrinogen dan D-dimer pada Pasien COVID-19 Rawat Inap. Medica Hospitalia, 8(2), pp.172–178.
Long, H., Nie, L., Xiang, X., Li, H., Zhang, X., Fu, X., Ren, H., Liu, W., Wang, Q. and Wu, Q., (2020.) D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. BioMed Research International, 2020, pp.1–10. https://doi.org/10.1155/2020/6159720.
Magdalena, Sugiri, Y. jane, Tantular, R. and Listyoko, A., (2021). Karakteristik Klinis Pasien COVID-19 di Rumah Sakit Dr. Saiful Anwar, Malang. Jurnal Respirologi Indonesia, 41(1), pp.7–14.
McMichael T, Currie D, Clark S, Pogosjans S, Kay M, Schwartz N, Lewis J, Baer A, Kawakami V, Lukoff M, Ferro J, Brostrom C, Rea T, Sayre M, Riedo F, Russell D, Hiatt B, Montgomery P, Rao A, Chow E, Tobolowsky F, Hughes M, Bardossy A, Oakley L, Jacobs J, Stone N, Reddy S, Jernigan J, Honein M, Clark T and Duchin J, (2020). Epidemiology of COVID-19 in a long-term care facility in King County, Washington. The New England Journal of Medicine, 382(21), pp.2005–2011.
Moreno, G., Carbonell, R., Bodí, M. and Rodríguez, A., (2021). Systematic Review of The Prognostic Utility of D-dimer, Disseminated Intravascular Coagulation, and Anticoagulant Therapy in COVID-19 Critically Ill Patients. Medicina Intensiva, 45, pp.42–55. https://doi.org/10.1016/j.medine.2020.06.006.
Mubarak, R., Esa, T., Widaningsih, Y. and Bahrun, U., (2021). D-Dimer Analysis in COVID-19 Patients. Indonesian Journal of Clinical Pathology and Medical Laboratory, https://doi.org/10.24293/ijcpml.v28i1.181
Omer, S.A.M., Abdallah, E.I., Muddathir, A.R.M., Omer, A.E. and Eltayeb, L.B., (2022). D-Dimer Level Among COVID-19 Patients as Biological Mediator for Hyper Coagulation State. Pakistan Journal of Biological Sciences, 25(6), pp.569–574. https://doi.org/10.3923/pjbs.2022.569.574.
Poudel, A., Poudel, Y., Adhikari, A., Aryal, B.B., Dangol, D., Bajracharya, T., Maharjan, A. and Gautam, R., (2021). D-dimer as A Biomarker for Assessment of COVID-19 Prognosis: D-dimer Levels on Admission and Its Role in Predicting Disease Outcome in Hospitalized Patients with COVID-19. PLoS ONE, [online] 16(8), pp.1–13. https://doi.org/10.1371/journal.pone.0256744.
PRISMA, (2020). Flow Diagram for New Systematic Review. [online] Available at: <http://www.prisma-statement.org/PRISMAStatement/FlowDiagram>.
Samudrala, P.K., Kumar, P., Choudhary, K., Thakur, N., Wadekar, G.S., Dayaramani, R., Agrawal, M. and Alexander, A., (2020). Virology, Pathogenesis, Diagnosis and In-line Treatment of COVID-19. European Journal of Pharmacology, 883, pp.1–12. https://doi.org/10.1016/j.ejphar.2020.173375.
Spiezia, L., Boscolo, A., Poletto, F., Cerruti, L., Tiberio, I., Campello, E., Navalesi, P. and Simioni, P., (2020). COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thrombosis and Haemostasis, 120(6), pp.998–1000. https://doi.org/10.1055/s-0040-1710018.
Sutrisno, Romdhoni, A., Andrianto and Machin, A., (2021). Manifestasi Klinis Multiorgan COVID-19. Surabaya: Airlangga University Press.
Vepa, A., Bae, J.P., Ahmed, F., Pareek, M. and Khunti, K., (2020). COVID-19 and Ethnicity: A novel Pathophysiological Role for Inflammation. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), pp.1043–1051. https://doi.org/10.1016/j.dsx.2020.06.056.
WHO, (2021). Living Guidance for clinical management of COVID-19. World Health Organization, [online] (November), p.63. Available at: <https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1>.
Wool, G.D. and Miller, J.L., (2021). The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology, https://doi.org/10.1159/000512007.
Yusra and Pangestu, N., (2020). Pemeriksaan Laboratorium pada Coronavirus Disease 2019 (COVID-19). Medica Hospitalia, Vol. 7(1A), pp.304–319.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ismi Andina Pertiwi, Tantri Analisawati Sudarsono, Dita Pratiwi Kusuma Wardani, Minto Rahaju
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All rights reserved. This publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording.
